• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CMRX:US

20.4900 USD 1.2500 6.50%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Chimerix Inc (CMRX)

Open: 19.2000 Day's Range: 19.1200 - 20.8200 Volume: 217,603
Previous Close: 19.2400 52wk Range: 12.9600 - 27.6911 1-Yr Rtn: +8.87%

Stock Chart for CMRX

No chart data available.
  • CMRX:US 20.4900
  • 1D
  • 1M
  • 1Y
19.2400
Interactive CMRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -24.0600
Est. EPS (USD) (12/2014) -1.5420
Est. PEG Ratio -
Market Cap (M USD) 548.37
Shares Outstanding (M) 26.76
30 Day Average Volume 362,622
Price/Book (mrq) 5.0625
Price/Sale (ttm) 16.2872
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMRX

Chimerix, Inc. is a biopharmaceutical discovers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in the United States.

M Michelle BerreyPres/CEO/Chief Medical OfficerLinda M RichardsonChief Commercial Officer
Michael D RogersChief Development OfficerTimothy W Trost "Tim"Senior VP/CFO/Secretary
More Company Profile & Key Executives for CMRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil